Gilead Sciences stock (NASDAQ: GILD) has seen a 14% fall this year, in line with the 15% fall for the broader S&P500 index.
Gilead Sciences stock (NASDAQ: GILD) has seen a 14% fall this year, in line with the 15% fall for the broader S&P500 index.